EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Surveillance Post Surgery for Retroperitoneal Soft Tissue Sarcoma

John Whitaker, Carolyn Nessim iD, Max Almond, Samuel J Ford

Current Oncology · 2023

DOI: 10.3390/curroncol30030211 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Oncology, 2023. Verfasst von John Whitaker und 3 weiteren Autor:innen. Beteiligte Einrichtung: Midlands Abdominal and Retroperitoneal Sarcoma Unit (MARSU), Queen Elizabeth Hospital Birmingham, Birmingham B15 2GW, UK. Hauptthemen laut MEDLINE: Sarcoma, Retroperitoneal Neoplasms, Soft Tissue Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Complete en bloc surgical resection offers the best opportunity for the cure of primary retroperitoneal sarcomas (RPS). The potential for disease recurrence, in the form of both loco-regional recurrence and distant metastases, underpins the rationale for postoperative surveillance. There is a paucity of high-quality evidence underpinning follow-up for RPS patients, and most practice guidelines draw from expert opinion and evidence from soft tissue sarcomas of the extremities. The available observational retrospective data analysis has failed to demonstrate that high-intensity radiological surveillance improves the overall survival in patients. The lack of a robust evidence base has given rise to variations in approaches to post-operative surveillance strategies adopted by specialist centres managing RPS across the world. More high-quality prospective research is needed and planned to more clearly support surveillance approaches that balance oncologic outcomes, patient-centric care, and health service value. Risk stratification tools exist and are available for use in routine practice. Their use will likely support more individualised post-operative surveillance moving forward. Surveillance will likely be underpinned by serial radiological imaging for the medium term. However, developments in genomics offer hope for biomarkers such as ctDNA to impact patient care positively in the future and further support individualised patient care pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcomaRetroperitoneal NeoplasmsSoft Tissue NeoplasmsHumansRetrospective StudiesProspective StudiesNeoplasm Recurrence, Local

Stichwörter der Autor:innen

diagnostic imaginghealth servicesretroperitoneal neoplasmssarcoma

Autor:innen und Institutionen

  • Midlands Abdominal and Retroperitoneal Sarcoma Unit (MARSU), Queen Elizabeth Hospital Birmingham, Birmingham B15 2GW, UK.
  • Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK.
  • Academic Department of Military Surgery and Trauma, Royal Centre for Defence Medicine, Birmingham B15 2SQ, UK.
  • Department of General Surgery, Division of Surgical Oncology, The Ottowa Hospital, 501 Smyth Road, Ottawa, ON K1H 8L6, Canada.

ORCID-Profile: Carolyn Nessim

Zitieren

APA

Whitaker, J., Nessim, C., Almond, M., & Ford, S. J. (2023). Surveillance Post Surgery for Retroperitoneal Soft Tissue Sarcoma. Current Oncology. https://doi.org/10.3390/curroncol30030211

Vancouver

Whitaker J, Nessim C, Almond M, Ford SJ. Surveillance Post Surgery for Retroperitoneal Soft Tissue Sarcoma. Current Oncology. 2023. doi:10.3390/curroncol30030211

BibTeX
@article{Whitaker2023,
  author = {Whitaker, John and Nessim, Carolyn and Almond, Max and Ford, Samuel J},
  title = {Surveillance Post Surgery for Retroperitoneal Soft Tissue Sarcoma},
  journal = {Current Oncology},
  year = {2023},
  doi = {10.3390/curroncol30030211}
}
Kostenlos starten →